Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 4, 2012, Pages 487-495

  Takigawa, Masateru ^a   Yamada, Takumi ^b   Yoshida, Yukihiko ^a   Ando, Monami ^a   Ishikawa, Kiyotake ^a   Aoyama, Yutaka ^a   Yamamoto, Takashi ^a   Inoue, Natsuo ^a   Tatematsu, Yasushi ^a   Nanasato, Mamoru ^a   Kato, Kazuo ^a   Tsuboi, Naoya ^c   Hirayama, Haruo ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^c CHUKYO HOSPITAL   (Japan)

Author keywords

atrial fibrillation; encircling ipsilateral pulmonary veins isolation; left atrium; recurrence; Renin angiotensin system inhibitors

Indexed keywords

ADULT; ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; ENCIRCLING IPSILATERAL PULMONARY VEINS ISOLATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CARDIOVASCULAR SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY VEINS; RECURRENCE; RENIN-ANGIOTENSIN SYSTEM; VASODILATION;

EID: 84870012308     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312446212     Document Type: Article

References (36)

1. Burstein B, Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008 ; 51: 802-809
2. Goette A, Lendeckel U. Electrophysiological effects of angiotensin II. Part I: Signal transduction and basic electrophysiological mechanisms. Europace. 2008 ; 10: 238-241
3. Novo G, Guttilla D, Fazio G, et al. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br J Clin Pharmacol. 2008 ; 66: 345-351
4. Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: Primary prevention. Europace. 2011 ; 13: 308-328
5. Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: Secondary prevention. Europace. 2011 ; 13: 610-625
6. Disertori M, Latini R, Barlera S, et al. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med. 2009 ; 360: 1606-1617
7. Yamashita T, Inoue H, Okumura K, et al. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). Europace. 2011 ; 13: 473-479
8. Yusuf S, Healey JS, Pogue J, et al. Irbesartan in patients with atrial fibrillation. N Engl J Med. 2011 ; 364: 928-938
9. Ouyang F, Ernst S, Vogtmann T, et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: Critical isthmus block can prevent atrial tachycardia recurrence. Circulation. 2002 ; 105: 1934-1942
10. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001 ; 104: 2539-2544
11. Ernst S, Ouyang F, Lober F, et al. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: An electroanatomic study. J Am Coll Cardiol. 2003 ; 42: 1271-1282
12. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003 ; 108: 2355-2360
13. Ho SY, Sanchez-Quintana D, Cabrera JA, et al. Anatomy of the left atrium: Implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999 ; 10: 1525-1533
14. Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004 ; 109: 327-334
15. Belluzzi F, Sernesi L, Preti P, et al. Prevention of recurrent lone atrial fibrillation by the angiotensin-ii converting enzyme inhibitor ramipril in normotensive patients. J Am Coll Cardiol. 2009 ; 53: 24-29
16. Richter B, Derntl M, Marx M, et al. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: No effect on ablation outcome after ablation of atrial fibrillation. Am Heart J. 2007 ; 153: 113-119
17. Al Chekakie MO, Akar JG, Wang F, et al. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol. 2007 ; 18: 942-946
18. Tayebjee MH, Creta A, Moder S, et al. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation. Europace. 2010 ; 12: 1537-1542
19. Zheng B, Kang J, Tian Y, et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation. Acta Cardiol. 2009 ; 64: 335-334
20. Berkowitsch A, Neumann T, Kuniss M, et al. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: Who is a responder?. Pacing Clin Electrophysiol. 2010 ; 33: 1101-1111
21. Ishikawa K, Yamada T, Yoshida Y, et al. Renin-angiotensin system blocker use may be associated with suppression of atrial fibrillation recurrence after pulmonary vein isolation. Pacing Clin Electrophysiol. 2011 ; 34: 296-303
22. Knackstedt C, Gramley F, Schimpf T, et al. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovasc Pathol. 2008 ; 17: 318-324
23. Shi Y, Li D, Tardif JC, et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res. 2002 ; 54: 456-461
24. Shinagawa K, Shi YF, Tardif JC, et al. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation. 2002 ; 105: 2672-2678
25. Cha TJ, Ehrlich JR, Zhang L, et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation. 2004 ; 109: 412-418
26. Kumagai K, Nakashima H, Urata H, et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol. 2003 ; 41: 2197-2204
27. Nakashima H, Kumagai K. Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model. Circ J. 2007 ; 71: 1977-1982
28. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 2001 ; 104: 2608-2614
29. Zhao J, Li J, Li Y, et al. Effects of spironolactone on atrial structural remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol. 2010 ; 159: 1584-1594
30. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998 ; 339: 659-666
31. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999 ; 100: 1879-1886
32. Valles E, Fan R, Roux JF, et al. Localization of atrial fibrillation triggers in patients undergoing pulmonary vein isolation: Importance of the carina region. J Am Coll Cardiol. 2008 ; 52: 1413-1420
33. Oral H, Ozaydin M, Tada H, et al. Mechanistic significance of intermittent pulmonary vein tachycardia in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2002 ; 13: 645-650
34. O'Donnell D, Furniss SS, Bourke JP. Paroxysmal cycle length shortening in the pulmonary veins during atrial fibrillation correlates with arrhythmogenic triggering foci in sinus rhythm. J Cardiovasc Electrophysiol. 2002 ; 13: 124-128
35. Ouyang F, Bansch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation. 2004 ; 110: 2090-2096
36. Nilsson B, Chen X, Pehrson S, et al. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial versus the extraostial ablation strategy. Am Heart J. 2006 ; 152: 537.e1 - e8